✦ LIBER ✦

Defining a Hodgkin lymphoma population for novel therapeutics after relapse from autologous hematopoietic cell transplant

✍ Scribed by Arai, Sally; Fanale, Michelle; deVos, Sven; Engert, Andreas; Illidge, Tim; Borchmann, Peter; Younes, Anas; Morschhauser, Franck; McMillan, Alex; Horning, Sandra J.

Book ID: 120323535
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 424 KB
Volume: 54
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2013.798868

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Managing Hodgkin lymphoma relapsing afte

Managing Hodgkin lymphoma relapsing after autologous hematopoietic cell transplantation: a not-so-good cancer after all!

✍ Kharfan-Dabaja, M A; Hamadani, M; Sibai, H; Savani, B N 📂 Article 📅 2014 🏛 Nature Publishing Group 🌐 English ⚖ 332 KB

Hodgkin’s lymphoma relapsing after autol

Hodgkin’s lymphoma relapsing after autologous transplantation: allogeneic hematopoietic stem cell transplantation using a strategy of reduced intensity conditioning, and T-cell depletion with T-cell add-back

✍ Frank Verholen; Marianne Terrettaz; Eddy Roosnek; Jakob R. Passweg; Yves Chaland 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

CNS Remission Predicts Survival After Au

CNS Remission Predicts Survival After Autologous Hematopoietic Stem Cell Transplantation (AHCT) For Non-Hodgkin Lymphoma (NHL) With Pre-Existing CNS Involvement: A CIBMTR Analysis

✍ R.T. Maziarz; Z. Wang; M.-J. Zhang; G.G. Laport; H.M. Lazarus; S. Montoto; P.N. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Treatment strategy based on gemcitabine-

Treatment strategy based on gemcitabine-containing salvage chemotherapy used with intent to proceed to second stem cell transplant for patients with Hodgkin lymphoma relapsing after a prior autologous transplant

✍ Czyz, Anna; Romejko-Jarosinska, Joanna; Knopinska-Posluszny, Wanda; Nowicki, Ada 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 250 KB

LACE-conditioned autologous stem cell tr

LACE-conditioned autologous stem cell transplantation for relapsed or refractory Hodgkin's lymphoma: treatment outcome and risk factor analysis in 67 patients from a single centre

✍ Perz, J B; Giles, C; Szydlo, R; O'Shea, D; Sanz, J; Chaidos, A; Wagner, S; Davis 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 149 KB

A Novel Hematopoietic Progenitor Cell (H

A Novel Hematopoietic Progenitor Cell (HPC) Mobilization Regimen, Utilizing Bortezomib and Filgrastim (G-CSF), for Patients Undergoing Autologous HPC Transplant (AHPCT) for Multiple Myeloma (MM) and Non-Hodgkin's Lymphoma (NHL)

✍ Abhyankar, Sunil; DeJarnette, Shaun; Bunch, Jennifer; Merkel, Dean; Ganguly, Sid 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 57 KB